Dna Brands Stock Working Capital
DNA Brands fundamentals help investors to digest information that contributes to DNA Brands' financial success or failures. It also enables traders to predict the movement of DNA Pink Sheet. The fundamental analysis module provides a way to measure DNA Brands' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to DNA Brands pink sheet.
DNA |
DNA Brands Company Working Capital Analysis
DNA Brands' Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current DNA Brands Working Capital | (3.12 M) |
Most of DNA Brands' fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, DNA Brands is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
CompetitionAccording to the company's disclosures, DNA Brands has a Working Capital of (3.12 Million). This is 100.16% lower than that of the Beverages sector and significantly lower than that of the Consumer Staples industry. The working capital for all United States stocks is 100.21% higher than that of the company.
DNA Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses DNA Brands' direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of DNA Brands could also be used in its relative valuation, which is a method of valuing DNA Brands by comparing valuation metrics of similar companies.DNA Brands is currently under evaluation in working capital category among its peers.
DNA Fundamentals
| Operating Margin | (0.98) % | |||
| Current Valuation | 1.47 M | |||
| Shares Outstanding | 22.07 K | |||
| Price To Earning | 0.20 X | |||
| Price To Sales | 0.11 X | |||
| Revenue | 249.01 K | |||
| Gross Profit | 249.01 K | |||
| EBITDA | (239.66 K) | |||
| Net Income | (1.25 M) | |||
| Cash And Equivalents | 499 | |||
| Total Debt | 2 M | |||
| Current Ratio | 0.01 X | |||
| Book Value Per Share | (0.92) X | |||
| Cash Flow From Operations | (1.1 M) | |||
| Earnings Per Share | 0.02 X | |||
| Beta | 1.14 | |||
| Market Capitalization | 33.98 K | |||
| Total Asset | 327 K | |||
| Retained Earnings | (30.44 M) | |||
| Working Capital | (3.12 M) | |||
| Current Asset | 319 K | |||
| Current Liabilities | 3.43 M |
About DNA Brands Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze DNA Brands's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of DNA Brands using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of DNA Brands based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for DNA Pink Sheet Analysis
When running DNA Brands' price analysis, check to measure DNA Brands' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DNA Brands is operating at the current time. Most of DNA Brands' value examination focuses on studying past and present price action to predict the probability of DNA Brands' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DNA Brands' price. Additionally, you may evaluate how the addition of DNA Brands to your portfolios can decrease your overall portfolio volatility.